A citation-based method for searching scientific literature

Glenwood Goss, Chun-Ming Tsai, Frances A Shepherd, Lyudmila Bazhenova, Jong Seok Lee, Gee-Chen Chang, Lucio Crino, Miyako Satouchi, Quincy Chu, Toyoaki Hida, Ji-Youn Han, Oscar Juan, Frank Dunphy, Makoto Nishio, Jin-Hyoung Kang, Margarita Majem, Helen Mann, Mireille Cantarini, Serban Ghiorghiu, Tetsuya Mitsudomi. Lancet Oncol 2016
Times Cited: 368



Myung-Ju Ahn, Chun-Ming Tsai, Frances A Shepherd, Lyudmila Bazhenova, Lecia V Sequist, Toyoaki Hida, James C H Yang, Suresh S Ramalingam, Tetsuya Mitsudomi, Pasi A J√§nne, Helen Mann, Mireille Cantarini, Glenwood Goss. Cancer 2019
Times Cited: 63




List of shared articles



Times cited

Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non-small Cell Lung Cancer.
Helena A Yu, Luis G Paz-Ares, James Chih-Hsin Yang, Ki Hyeong Lee, Pilar Garrido, Keunchil Park, Joo-Hang Kim, Dae Ho Lee, Huzhang Mao, Sameera R Wijayawardana,[...]. Clin Cancer Res 2021
9

Beyond Osimertinib: The Development of Third-Generation EGFR Tyrosine Kinase Inhibitors For Advanced EGFR+ NSCLC.
Misako Nagasaka, Viola W Zhu, Sun Min Lim, Michael Greco, Fengying Wu, Sai-Hong Ignatius Ou. J Thorac Oncol 2021
5


Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies.
Myung-Ju Ahn, Ji-Youn Han, Dong-Wan Kim, Byoung Chul Cho, Jin-Hyoung Kang, Sang-We Kim, James Chih-Hsin Yang, Tetsuya Mitsudomi, Jong Seok Lee. Cancer Res Treat 2020
1

Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non-small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy.
Alessandro Dal Maso, Martina Lorenzi, Elisa Roca, Sara Pilotto, Marianna Macerelli, Valentina Polo, Fabiana Letizia Cecere, Alessandro Del Conte, Giorgia Nardo, Vanessa Buoro,[...]. Clin Lung Cancer 2020
11

Predictive value of tumor genetic alteration profiling for chemotherapy and EGFR-TKI treatment in advanced NSCLC.
Wei Jiang, Aiping Zeng, Ruiling Ning, Wenhua Zhao, Cuiyun Su, Huilin Wang, Shaozhang Zhou, Qitao Yu. Oncol Lett 2020
1